{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:55:46Z","timestamp":1770965746114,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T00:00:00Z","timestamp":1110412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T00:00:00Z","timestamp":1110412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1038\/sj.gt.3302489","type":"journal-article","created":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T21:01:48Z","timestamp":1110488508000},"page":"980-987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism"],"prefix":"10.1038","volume":"12","author":[{"given":"J","family":"Rutanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-M","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Teittinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T T","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Heikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Koponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Gruchala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Inkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Jauhiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M O","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M P","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Stacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M G","family":"Achen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,10]]},"reference":[{"key":"BF3302489_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/01.CIR.97.13.1298","volume":"97","author":"CR Narins","year":"1998","unstructured":"Narins CR, Holmes DRJ, Topol EJ . A call for provisional stenting: the balloon is back!. Circulation 1998; 97: 1298\u20131305.","journal-title":"Circulation"},{"key":"BF3302489_CR2","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.ATV.20.6.1512","volume":"20","author":"I Zachary","year":"2000","unstructured":"Zachary I, Mathur A, Yla-Herttuala S, Martin J . Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2000; 20: 1512\u20131520.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF3302489_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/70928","volume":"5","author":"N Ferrara","year":"1999","unstructured":"Ferrara N, Alitalo K . Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359\u20131364.","journal-title":"Nat Med"},{"key":"BF3302489_CR4","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1161\/01.CIR.102.18.2262","volume":"102","author":"MO Hiltunen","year":"2000","unstructured":"Hiltunen MO et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation 2000; 102: 2262\u20132268.","journal-title":"Circulation"},{"key":"BF3302489_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/10430340050016003","volume":"11","author":"M Laitinen","year":"2000","unstructured":"Laitinen M et al. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther 2000; 11: 263\u2013270.","journal-title":"Hum Gene Ther"},{"key":"BF3302489_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/mthe.2002.0638","volume":"6","author":"K Makinen","year":"2002","unstructured":"Makinen K et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002; 6: 127\u2013133.","journal-title":"Mol Ther"},{"key":"BF3302489_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"M Hedman","year":"2003","unstructured":"Hedman M et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677\u20132683.","journal-title":"Circulation"},{"key":"BF3302489_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen MG et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998; 95: 548\u2013553.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302489_CR9","doi-asserted-by":"publisher","first-page":"32127","DOI":"10.1074\/jbc.274.45.32127","volume":"274","author":"SA Stacker","year":"1999","unstructured":"Stacker SA et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 1999; 274: 32127\u201332136.","journal-title":"J Biol Chem"},{"key":"BF3302489_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0008-6363(03)00518-2","volume":"59","author":"J Rutanen","year":"2003","unstructured":"Rutanen J et al. Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc Res 2003; 59: 971\u2013979.","journal-title":"Cardiovasc Res"},{"key":"BF3302489_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1096\/fj.00-0145com","volume":"14","author":"MO Hiltunen","year":"2000","unstructured":"Hiltunen MO et al. Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J 2000; 14: 2230\u20132236.","journal-title":"FASEB J"},{"key":"BF3302489_CR12","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen TT et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 2003; 92: 1098\u20131106.","journal-title":"Circ Res"},{"key":"BF3302489_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1161\/01.CIR.0000115519.03688.A2","volume":"109","author":"J Rutanen","year":"2004","unstructured":"Rutanen J et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004; 109: 1029\u20131035.","journal-title":"Circulation"},{"key":"BF3302489_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0008-6363(96)00038-7","volume":"31","author":"C Bauters","year":"1996","unstructured":"Bauters C et al. Mechanisms and prevention of restenosis: from experimental models to clinical practice. Cardiovasc Res 1996; 31: 835\u2013846.","journal-title":"Cardiovasc Res"},{"key":"BF3302489_CR15","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1161\/01.CIR.91.11.2793","volume":"91","author":"T Asahara","year":"1995","unstructured":"Asahara T et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793\u20132801.","journal-title":"Circulation"},{"key":"BF3302489_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s001099900019","volume":"77","author":"N Ferrara","year":"1999","unstructured":"Ferrara N . Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77: 527\u2013543.","journal-title":"J Mol Med"},{"key":"BF3302489_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00004872-199715030-00009","volume":"15","author":"R Sarkar","year":"1997","unstructured":"Sarkar R, Gordon D, Stanley JC, Webb RC . Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells. J Hypertens 1997; 15: 275\u2013283.","journal-title":"J Hypertens"},{"key":"BF3302489_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.RES.82.1.21","volume":"82","author":"Z Yan","year":"1998","unstructured":"Yan Z, Hansson GK . Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 1998; 82: 21\u201329.","journal-title":"Circ Res"},{"key":"BF3302489_CR19","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1161\/01.ATV.17.10.2238","volume":"17","author":"A Kumar","year":"1997","unstructured":"Kumar A, Lindner V . Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997; 17: 2238\u20132244.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF3302489_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0735-1097(97)00070-3","volume":"29","author":"CV Serrano Jr","year":"1997","unstructured":"Serrano Jr CV et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997; 29: 1276\u20131283.","journal-title":"J Am Coll Cardiol"},{"key":"BF3302489_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","volume":"31","author":"R Kornowski","year":"1998","unstructured":"Kornowski R et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224\u2013230.","journal-title":"J Am Coll Cardiol"},{"key":"BF3302489_CR22","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/hq1101.098230","volume":"21","author":"JH Brasen","year":"2001","unstructured":"Brasen JH et al. Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries. Arterioscler Thromb Vasc Biol 2001; 21: 1720\u20131726.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF3302489_CR23","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","volume":"105","author":"A Farb","year":"2002","unstructured":"Farb A et al. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974\u20132980.","journal-title":"Circulation"},{"key":"BF3302489_CR24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/01.RES.76.6.980","volume":"76","author":"AM Zeiher","year":"1995","unstructured":"Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R . Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 1995; 76: 980\u2013986.","journal-title":"Circ Res"},{"key":"BF3302489_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.CIR.96.3.934","volume":"96","author":"PS Tsao","year":"1997","unstructured":"Tsao PS et al. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 1997; 96: 934\u2013940.","journal-title":"Circulation"},{"key":"BF3302489_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1172\/JCI118074","volume":"96","author":"R De Caterina","year":"1995","unstructured":"De Caterina R et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60\u201368.","journal-title":"J Clin Invest"},{"key":"BF3302489_CR27","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1161\/01.CIR.99.23.2979","volume":"99","author":"H Qian","year":"1999","unstructured":"Qian H et al. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-Fed rabbits. Circulation 1999; 99: 2979\u20132982.","journal-title":"Circulation"},{"key":"BF3302489_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9150(98)00175-0","volume":"142","author":"DA Tsakiris","year":"1999","unstructured":"Tsakiris DA et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142: 193\u2013200.","journal-title":"Atherosclerosis"},{"key":"BF3302489_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/01.ATV.21.3.327","volume":"21","author":"F Cipollone","year":"2001","unstructured":"Cipollone F et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327\u2013334.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF3302489_CR30","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1089\/hum.1998.9.10-1481","volume":"9","author":"M Laitinen","year":"1998","unstructured":"Laitinen M et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998; 9: 1481\u20131486.","journal-title":"Hum Gene Ther"},{"key":"BF3302489_CR31","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/01.CIR.0000117234.08626.7C","volume":"109","author":"O Leppanen","year":"2004","unstructured":"Leppanen O et al. Oral imatinib mesylate (STI571\/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation 2004; 109: 1140\u20131146.","journal-title":"Circulation"},{"key":"BF3302489_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nm0603-694","volume":"9","author":"S Yla-Herttuala","year":"2003","unstructured":"Yla-Herttuala S, Alitalo K . Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694\u2013701.","journal-title":"Nat Med"},{"key":"BF3302489_CR33","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1089\/hum.1998.9.12-1769","volume":"9","author":"AM Puumalainen","year":"1998","unstructured":"Puumalainen AM et al. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther 1998; 9: 1769\u20131774.","journal-title":"Hum Gene Ther"},{"key":"BF3302489_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/bbrc.1998.9095","volume":"249","author":"MK Jones","year":"1998","unstructured":"Jones MK, Sarfeh IJ, Tarnawski AS . Induction of in vitro angiogenesis in the endothelial-derived cell line, EA hy926, by ethanol is mediated through PKC and MAPK. Biochem Biophys Res Commun 1998; 249: 118\u2013123.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302489_CR35","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1089\/hum.1997.8.15-1737","volume":"8","author":"M Laitinen","year":"1997","unstructured":"Laitinen M et al. Vegf gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 1997; 8: 1737\u20131744.","journal-title":"Hum Gene Ther"},{"key":"BF3302489_CR36","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1172\/JCI117971","volume":"95","author":"S Yl\u00e4-Herttuala","year":"1995","unstructured":"Yl\u00e4-Herttuala S et al. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 1995; 95: 2692\u20132698.","journal-title":"J Clin Invest"},{"key":"BF3302489_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s004280000239","volume":"437","author":"T Hakkinen","year":"2000","unstructured":"Hakkinen T, Karkola K, Yla-Herttuala S . Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch 2000; 437: 396\u2013405.","journal-title":"Virchows Arch"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302489","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:27:05Z","timestamp":1648614425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,10]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["BF3302489"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302489","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,10]]},"assertion":[{"value":"15 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}